Yitao Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yitao Yang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Chenxi Chang
National Institute of TCM Constitution and Preventive Medicine Beijing University of Chinese Medicine Beijing China
1 shared publication- Haiyun Zhang
School of Medicine Shanghai University Shanghai China
1 shared publication Honglei Zhang
National Institute of TCM Constitution and Preventive Medicine Beijing University of Chinese Medicine Beijing China
1 shared publicationHui Han
National Institute of TCM Constitution and Preventive Medicine Beijing University of Chinese Medicine Beijing China
1 shared publication- Ji Wang
National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine
1 shared publication Juntong Liu
National Institute of TCM Constitution and Preventive Medicine Beijing University of Chinese Medicine Beijing China
1 shared publication
Latest Publications
- Open Access
- 30 March 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (7) , e70503
Monocytes Expressing IL ‐ 36G Play a Crucial Role in Atopic Dermatitis
Atopic dermatitis ( ad ) is a chronic inflammatory skin disease, with recent studies indicating that immune cells, such as monocytes and inflammatory cytokines, play a crucial role. By retrieving datasets from public databases and analysing immune cell infiltration in lesional skin using CIBERSORT, we found that monocytes and M2 macrophages were significantly upregulated in atopic dermatitis. Differentially expressed gene (DEG) functional enrichment analysis revealed that cytokine‐cytokine receptor interaction was the most significantly enriched pathway. Further analysis of cytokines and their receptors, along with their correlation with infiltrating immune cells, identified IL36G‐expressing monocytes as a key target in atopic dermatitis. We compared immune cell infiltration and cytokine‐related targets in similar inflammatory skin diseases, such as psoriasis and urticaria, to evaluate similarities and differences among these three skin conditions. The analysis revealed that IL36G‐expressing monocytes were also highly expressed in psoriasis but did not play a pivotal role in urticaria. Finally, we used molecular docking to predict and validate drugs targeting IL36G. Our study highlights IL36G‐expressing monocytes as a common key target in atopic dermatitis and psoriasis, offering novel insights and therapeutic strategies for these related diseases.
- 30 March 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (7) , e70503
Open AccessMonocytes Expressing IL ‐ 36G Play a Crucial Role in Atopic Dermatitis
Atopic dermatitis ( ad ) is a chronic inflammatory skin disease, with recent studies indicating that immune cells, such as monocytes and inflammatory cytokines, play a crucial role. By retrieving datasets from public databases and analysing immune cell infiltration in lesional skin using CIBERSORT, we found that monocytes and M2 macrophages were significantly upregulated in atopic dermatitis. Differentially expressed gene (DEG) functional enrichment analysis revealed that cytokine‐cytokine receptor interaction was the most significantly enriched pathway. Further analysis of cytokines and their receptors, along with their correlation with infiltrating immune cells, identified IL36G‐expressing monocytes as a key target in atopic dermatitis. We compared immune cell infiltration and cytokine‐related targets in similar inflammatory skin diseases, such as psoriasis and urticaria, to evaluate similarities and differences among these three skin conditions. The analysis revealed that IL36G‐expressing monocytes were also highly expressed in psoriasis but did not play a pivotal role in urticaria. Finally, we used molecular docking to predict and validate drugs targeting IL36G. Our study highlights IL36G‐expressing monocytes as a common key target in atopic dermatitis and psoriasis, offering novel insights and therapeutic strategies for these related diseases.